about
Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesLigand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive propertiesC-ring cannabinoid lactones: a novel cannabinergic chemotype.Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist.Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in miceExposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats.Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligandsCannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases.The interaction of cannabinoid receptor agonists, CP55940 and WIN55212-2 with membranes using solid state 2H NMR.Synthesis and characterization of a compact tricyclic resorcinol from (+)- and (-)-3-pinanol.Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoidsControlled-deactivation cannabinergic ligands."Not for human consumption": a review of emerging designer drugs.1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.Intraocular pressure-lowering effect of oral paracetamol and its in vitro corneal penetration properties.Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model.In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
P2860
Q24631675-999A5A5B-0AF3-4039-8A4E-3F573B1E2187Q28245037-1A22C166-5DB0-4DF8-9217-E5262A66286FQ30580156-024A70A6-16ED-48B8-8C44-BF9D652AAC83Q33636166-3F3EB6E2-2780-4EF6-8F69-995E4D866A8DQ34142047-E180570A-B2BD-48C3-BD3F-08BF5DB0DECDQ34203193-0328C3D4-5BA7-4B54-90D9-BDE0A680578EQ34236794-7C04FFF5-EB9B-42C4-8934-9AC1AD5D7AF0Q34459132-0FC8E24B-90EA-467D-A955-06B4E1E99C5AQ34841008-2F411C15-EFE5-473A-9AAA-253B9E5E09AAQ35858501-DF9A194D-7D32-443C-8C00-14E66EB95AB3Q36335446-3049117C-CE62-4311-A355-52CFB3AC445BQ36734955-DC0EB270-FD1B-4B29-9952-E2A5EA40D33FQ36971357-335CB212-5B77-437A-98D6-9D57791AEB8AQ37177893-C73F1158-C5F6-43A9-AE02-71FEF93AC392Q37206915-675774C5-EC1D-4250-B0AB-038AE98A94F6Q37527191-4015EB79-5224-4185-91F5-6E65B4EF8344Q38202898-0340344A-98F2-4F4F-B7D1-56596B6836C3Q40126502-96215F35-E058-4FB7-BB0D-A5A748262698Q41833978-28671C1F-3CD1-446A-BC4D-747BB9D48379Q42921046-E0F45BFE-BB7C-456A-9D54-23E8936B2BB5Q53211337-C1D3BA28-8E7A-492B-BD65-E116E6EA2845Q53546061-1CBD8E34-212D-4FFD-9BC4-895CF46FAEB2
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
CB1 cannabinoid receptor ligands.
@ast
CB1 cannabinoid receptor ligands.
@en
type
label
CB1 cannabinoid receptor ligands.
@ast
CB1 cannabinoid receptor ligands.
@en
prefLabel
CB1 cannabinoid receptor ligands.
@ast
CB1 cannabinoid receptor ligands.
@en
P921
P356
P1476
CB1 cannabinoid receptor ligands.
@en
P2093
Ganesh A Thakur
Spyros P Nikas
P304
P356
10.2174/1389557054368772
P577
2005-07-01T00:00:00Z